Showing results (51-60 of 278) with videos related to

Sort By:
Pageof 28
JNCI Cancer Spectrum|July 31, 2019
Adjuvant Therapy and Mammographic Density Changes in Women With Breast CancerLouise Eriksson, Wei He, Mikael Eriksson, et al.
Cancer Treatment Reviews|July 8, 2021
Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysisCaroline Boman, Ioannis Zerdes, Kira Mårtensson, et al.
Molecular Oncology|December 15, 2015
Intrinsic subtypes and genomic signatures of primary breast cancer and prognosis after systemic relapseClaudette Falato, Nicholas P Tobin, Julie Lorent, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2006
Genomic instability and prognosis in breast carcinomasUlrike Kronenwett, Alexander Ploner, Anders Zetterberg, et al.
Acta Oncologica (Stockholm, Sweden)|April 25, 2007
Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancerHenrik Lindman, Gunnar Aström, Johan Ahlgren, et al.
BMC Cancer|March 2, 2012
The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancerGustaf Rosin, Ulf Hannelius, Linda Lindström, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2002
Pulmonary toxicity after radiotherapy in primary breast cancer patients: results from a randomized chemotherapy studyMicaela Hernberg, Pekka Virkkunen, Paula Maasilta, et al.
Nuclear Medicine Communications|March 15, 2006
Different methods for the detection of small changes in uptake between single-photon emission computed tomography (SPECT) examinations: 99mTc-sestamibi in chemotherapy for breast tumoursHans Jacobsson, Brigitte Wilczek, Jonas Bergh, et al.
Molecular Oncology|July 31, 2014
miR-206 inhibits cell migration through direct targeting of the actin-binding protein coronin 1C in triple-negative breast cancerJun Wang, Efrosini Tsouko, Philip Jonsson, et al.
BMC Cancer|October 15, 2013
Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studiesJelena Milosevic, Johanna Klinge, Anna-Lena Borg, et al.
Pageof 28